Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Sona Nanotech Inc C.SONA

Alternate Symbol(s):  SNANF

Technology Scientific & Technical Instruments
Sona Nanotech Inc. is a nanotechnology life sciences company that has developed multiple methods for the manufacturing of various types of gold nanoparticles. The Company is engaged in the research and development of its technology for use in multiplex diagnostic testing platforms and biomedical applications. Its gold nanotechnologies are adapted for use in applications, as a safe and delivery system for multiple medical treatments, for the approval of various regulatory boards, including Health Canada and the Food and Drug administration (FDA). Its gold nanorod particles are manufactured without the use of CTAB (cetyltrimethylammonium), eliminating the toxicity risks associated with the use of other gold nanorod technologies in medical applications. The Company leverages its core proprietary gold nanorod (GNR) manufacturing technology and laboratory assets to focus on the development of diagnostic tests and biologic reagents, and the advancement of its GNR intellectual property.


CSE:SONA - Post by User

Sona Nanotech Inc > Completed my program for future sales/share price
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(333)
•••
Comment by Specificon Jul 06, 2020 8:54pm
202 Views
Post# 31231672

RE:RE:Completed my program for future sales/share price

RE:RE:Completed my program for future sales/share price
dart321 wrote: the reason I built this program was because of these two things and I quote from their news releases, Technology transfer to manufacturers is currently underway to produce tests and " to meet """CURRENT""" and expected demand. Also said they will begin "TAKING" deposits on letters of intent an expressions of interest ( 10's of millions ). I guess news should flow soon. Those two things are why I did the program.


Very good presention dart.

Future sales will of course drive the sp

And sales are totally dependment on fda approval

What's the timeline dart 

When do u expect an fda decision ?

......cheers and gl
<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities